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Abstract
Background: BANK1 and BLK belong to the pleiotropic autoimmune genes; recently, epistasis between BANK1 and BLK was
detected in systemic lupus erythematosus. Although BLK has been reproducibly identified as a risk factor in rheumatoid
arthritis (RA), reports are conflicting about the contribution of BANK1 to RA susceptibility. To ascertain the real impact of
BANK1 on RA genetic susceptibility, we performed a large meta-analysis including our original data and tested for an
epistatic interaction between BANK1 and BLK in RA susceptibility.
Patients and Methods: We investigated data for 1,915 RA patients and 1,915 ethnically matched healthy controls
genotyped for BANK1 rs10516487 and rs3733197 and BLK rs13277113. The association of each SNP and RA was tested by
logistic regression. Multivariate analysis was then used with an interaction term to test for an epistatic interaction between
the SNPs in the 2 genes.
Results: None of the SNPs tested individually was significantly associated with RA in the genotyped samples. However, we
detected an epistatic interaction between BANK1 rs3733197 and BLK rs13277113 (Pinteraction = 0.037). In individuals carrying
the BLK rs13277113 GG genotype, presence of the BANK1 rs3733197 G allele increased the risk of RA (odds ratio 1.21 [95%
confidence interval 1.04–1.41], P= 0.015. Combining our results with those of all other studies in a large trans-ethnic meta-
analysis revealed an association of the BANK1 rs3733197 G allele and RA (1.11 [1.02–1.21], P= 0.012).
Conclusion: This study confirms BANK1 as an RA susceptibility gene and for the first time provides evidence for epistasis
between BANK1 and BLK in RA. Our results illustrate the concept of pleiotropic epistatic interaction, suggesting that BANK1
and BLK might play a role in RA pathogenesis.
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Introduction
Rheumatoid arthritis (RA) is a systemic, inflammatory, auto-
immune disorder that affects up to 1% of the general adult
population worldwide [1]. Nearly two-thirds of cases are
seropositive for rheumatoid factor (RF) or anti-citrullinated protein
autoantibodies (ACPA) [2]. RA is a complex disease implicating
environmental, genetic and stochastic factors. However, the
weight of genetics is underlined by family studies estimating that
more than 50% of the variance in disease risk is explained by
genetic factors [3]. To date, a genetic etiology for RA is
unequivocal: recent genome-wide association studies have identi-
fied at least 31 validated susceptibility loci and implicated a broad
array of biological pathways. These risk alleles explain about 16%
of the disease variance, so additional susceptibility variants remain
to be discovered [4].
Family-based epidemiology studies suggest a shared genetic
basis among several autoimmune diseases leading to the paradigm
of pleiotropy [5]. This genetic overlap is illustrated by the well-
known association of certain human leukocyte antigen (HLA) loci
and multiple human autoimmune diseases, as well as non-HLA risk
loci in diverse pathways such as PTPN22, STAT4, IRAK1 or IRF5
(reviewed in [6]).
BANK1, encoding the B-cell scaffold protein with ankyrin
repeats 1, is a Lyn tyrosine kinase substrate that promotes tyrosine
phosphorylation of inositol 1,4,5-trisphosphate receptors [7].
BANK1 has been convincingly identified as a risk factor for the
autoimmune diseases systemic lupus erythematosus (SLE) and
systemic sclerosis (SSc) [8–12]. However, in terms of the
contribution of BANK1 to RA susceptibility, case–control associ-
ation studies of the European Caucasian population gave
conflicting results [13–15]. The association signal for the human
BANK1 gene is located between exons 1 and 3, with 2
polymorphisms, rs17266594 and rs10516487, in very high linkage
disequilibrium (LD) with each other [8,14]. Recently, the
rs17266594 SNP, located in the branch-point consensus sequence,
was found to have a negligible effect on splicing or gene
expression, whereas the non-synonymous SNP rs10516487
(R61H) showed a dual nature by first influencing mRNA splicing
and then protein quantity and second producing a risk-variant-
containing protein isoform with increased potential for multi-
merization [16]. A third non-synonymous SNP, rs3733197,
(A383T) located in exon 7 and encoding the ankyrin repeat-like
motif, was found strongly associated with both SLE and SSc [8–
11].
BLK was also recently identified as a susceptibility gene for
multiple autoimmune phenotypic traits, including SLE [9,17,18],
SSc [19–21], Sjo¨gren’s syndrome [22] and RA [15,23–25]. BLK is
a Src tyrosine kinase specifically expressed in the B-cell lineage
[26]. The pleiotropic genetic variant of BLK, rs13277113, is
located in the promoter of BLK, and the risk genotypes may be
associated with reduced BLK mRNA levels in SLE [17].
Thus, both BANK1 and BLK, which encode for proteins
involved in B-cell signaling, could be considered autoimmune
pleiotropic genes. Of interest, a genetic and physical interaction of
BANK1 and BLK was recently detected in SLE [27]. We aimed to
re-evaluate the role of BANK1 in RA susceptibility and test
whether BANK1– BLK epistatis could be involved in the RA
genetic background, notably in the subset of patients positive for
specific autoantibodies.
Materials and Methods
Patients and controls
A total of 1,454 RA patients (820 from France and 634 from
Japan) and 1,542 ethnically matched healthy controls (1,220 from
France and 322 from Japan) were genotyped for BANK1
rs10516487 and rs3733197 and BLK rs13277113. These original
data were combined with already published data for 461 cases and
373 controls from Spain genotyped for the same 3 SNPs [13], for a
total of 1,915 RA cases and 1,915 ethnically matched healthy
controls. All RA patients were tested for 1) anti-CCP2 antibodies
detected by commercial ELISA (Immunoscan, Eurodiagnostica,
Arnheim, The Netherlands), and 2) RF by laser nephelometry.
All subjects provided informed, written consent as approved by
the institutional review boards for the recruiting sites of the
affiliated institutions (CPP IDF8, Paris, France; ethics committee,
University of Granada, Spain; and ethics committee, University of
Tsukuba, Japan).
To ascertain the real impact of BANK1 on RA susceptibility, we
performed a meta-analysis including our original data and
published data for 2,119 patients with RA and 2,163 controls
from Spain, Sweden, Argentina, and Mexico [14]. For meta-
analysis of BANK1 rs10516487, we included 5,325 RA patients and
11,780 controls from the United Kingdom: 1) 3,468 RA cases and
8,847 controls described in [15] with genotype and clinical
information kindly provided by Dr. Orozco and 2) 1,857 RA cases
and 2,933 controls from the Wellcome Trust Case Control
Consortium [28]. All patients fulfilled the American College of
Rheumatology 1987 revised classification criteria for RA [29].
Genotyping methods
Subjects were genotyped for BANK1 rs10516487 and rs3733197
and BLK rs13277113 by use of a competitive allele-specific PCR
system (Kaspar genotyping, Kbioscience, Hoddeston, UK) and
TaqMan 59 discrimination assay (Applied Biosystem, Foster City,
SA).
Statistical analysis
Statistical analyses involved use of R v2.13.1 (http://www.R-
project.org, the R Foundation for Statistical Computing, Vienna,
Austria). Tests of conformity to Hardy–Weinberg equilibrium
involved a standard chi-square test (1 degree of freedom [df]) of
differences between observed and expected genotype counts.
The association of SNPs and RA was tested by a logistic
regression model assuming multiplicative effects (i.e., with geno-
type AA as reference, the risk associated with the homozygous GG
genotype was assumed to be the square of the risk associated with
the AG genotype). To test for interaction between the alleles for
the two SNPs, we used a multivariate logistic regression model,
with the 2 main effects for each of the SNPs (assuming
multiplicative effects of the alleles at each locus) and an interaction
parameter. Analysis was performed for each sample separately, the
2 European Caucasian samples combined, and the whole sample
(after adjusting for country of origin). Significance of the
interaction parameter was tested by a 1-df likelihood-ratio test.
The corresponding P-values for epistasis were termed Pinteraction and
the odds ratio of the interaction parameter ORinteraction. We
performed a stratified analysis to estimate the ORs for BANK1
rs10516487 and rs3733197 alleles assuming a multiplicative model
for subsets of subjects carrying the AA, AG or GG genotypes of
BLK rs13277113.
Another test of interaction involved the Model Based Multifac-
tor Dimensionality Reduction (MB-MDR) method [30] with R
package MBMDR-3.0.2 [31]. This method is a dimension
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reduction method for exploring gene–gene interactions that
involves merging multilocus genotypes into a 1-D construct that
reflects the risk and can be represented by 3 values: high, low and
non-informative. The method consists of 3 steps. In the first step,
an association test is performed for each multilocus genotype and,
depending on the resulting p value, the mutilocus genotype is
assigned to 1 of the 3 categories: ‘‘high’’ if the p value is #0.1 and
the score is positive, ‘‘low’’ if the p value is #0.1 and the score is
negative and ‘‘undetermined’’ if the p value is .0.1. In a second
step, multilocus genotypes of the same risk category are merged
and 2 new association tests are performed, one for the high-risk
category and one for the low-risk category. To account for
multiple testing, the significance of the maximum of these two
Wald statistics is then assessed by permutations.
We performed a meta-analysis of the BANK1 association with
RA using the R package rmeta by pooling the results from the
current study for BANK1 and results from the literature by
searching the Medline database using the following keywords:
rheumatoid arthritis, gene, BANK1 [32]. The DerSimonian-Laird
random effects model [33] was used for allele counts in the
different samples. Heterogeneity between samples was tested by
the Q test [34] and the I2 statistic [35]. This study complies with
the PRISMA statement [36].
Table 1. Characteristics of rheumatoid arthritis cases
investigated for a BLK–BANK1 genetic interaction.
France* (N=806)
Spain
(N=461)
Japan*
(N=634)
Sex ratio (M/F) 0.31 0.34 0.24
Age at disease onset 43.07614.79 48.17616.15 48.47613.69
Disease duration 11.2867.92 15.4566.71 15.11610.62
Rheumatoid factor** 523 (70.1%) 347 (75.9%) 548 (86.6%)
Anti-CCP
antibodies**
479 (64.7%) 300 (65.1%) 556 (90.7%)
Erosive disease** 445 (58.1%) 87 (78.4%) 358 (56.5%)
Data are mean6SD or number (%) unless indicated.
*Genotype data for the 3 investigated single nucleotide polymorphisms were
available for 1,440 of 1,454 RA cases from France and Japan.
**The percentage refers to percentage of positive patients among those with
available data.
doi:10.1371/journal.pone.0061044.t001
Figure 1. Results of single marker analysis in populations genotyped for both BANK1 and BLK. Number of cases and controls, frequency
of G allele, odds ratio (OR) and 95% confidence interval (95% CI) and P-value of the association under a multiplicative model for each population
separately, for European Caucasians and for the combined dataset (France, Spain and Japan).
doi:10.1371/journal.pone.0061044.g001
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Results
For both French and Japanese samples, the genotyping success
rate was .95%, with no significant departure from Hardy–
Weinberg equilibrium at p,0.05. In addition, control allelic
frequencies for BANK1 rs10516487 and rs3733197 and BLK
rs13277113 were similar to those reported for the European
Caucasian and Japanese populations in the HapMap project
(http://hapmap.ncbi.nlm.nih.gov/).
We had available genotype data for the 3 markers for 1,901 RA
patients (806 from France, 461 from Spain and 634 from Japan)
and 1,898 ethnically matched controls. The characteristics of RA
patients are in Table 1.
Analysis of single BANK1 SNPs failed to detect an association
with RA in each population investigated (i.e., French, Spanish and
Japanese) or the combined population (Figure 1). Similarly, we
found no association of BLK rs13277113 and RA in all populations
investigated (Figure 1).
We found an interaction between BANK1 rs3733197 and BLK
rs13277113 in the European Caucasian population (ORinterac-
tion = 1.23 [95% confidence interval (95% CI) 1.02–1.48],
Pinteraction=0.032). The risk of RA was increased with the G risk
allele of BANK1 rs3733197 only for individuals carrying the GG
homozygous genotype of BLK rs13277113 (ORG/GG=1.22 [1.04–
1.42], P=0.013). We found no effect of the rs3733197 G allele in
subjects carrying the rs13277113 AG or AA genotypes (ORG/
AG=1.02 [0.84–1.23], P=0.86, and ORG/AA=0.77 [0.49–1.21],
Figure 2. Epistasis between BANK1 rs3733197 and BLK rs13277113. OR for trend for the G allele of BANK1 rs3733197 and the three BLK
rs13277113 genotypes by population (France, Spain and Japan).
doi:10.1371/journal.pone.0061044.g002
Table 2. Epistasis between BANK1 rs3733197 and BLK rs13277113 in rheumatoid arthritis: association of BANK rs3733197 G allele
and BLK rs13277113 genotypes.
Sample N cases N controls Freq Cases Freq Controls OR [95%CI] P-value
BLK rs13277113 GG genotype
France 479 674 0.697 0.667 1.16 [0.96–1.39] 0.110
Spain 275 213 0.722 0.662 1.37 [1.03–1.84] 0.033
European Caucasian 754 887 0.706 0.666 1.22 [1.04–1.42] 0.013
Japan 59 41 0.830 0.829 1.01 [0.46–2.18] 0.981
Combined* 813 928 0.715 0.673 1.21 [1.04–1.41] 0.015
BLK rs13277113 AG genotype
France 280 458 0.659 0.666 0.97 [0.78–1.21] 0.784
Spain 162 132 0.738 0.708 1.15 [0.81–1.64] 0.439
European Caucasian 442 590 0.588 0.675 1.02 [0.84–1.23] 0.861
Japan 268 142 0.862 0.873 0.91 [0.59–1.37] 0.663
Combined* 710 732 0.753 0.714 0.99 [0.84–1.18] 0.981
BLK rs13277113 AA genotype
France 47 71 0.649 0.669 0.91 [0.53–1.59] 0.752
Spain 24 28 0.604 0.750 0.52 [0.22–1.18] 0.129
European Caucasian 71 99 0.634 0.692 0.77 [0.49–1.21] 0.260
Japan 307 139 0.837 0.867 0.78 [0.51–1.17] 0.248
Combined* 378 238 0.799 0.794 0.78 [0.57–1.05] 0.107
Freq: frequency of the BANK1 rs3733197 G risk allele, OR [95%CI]: odds ratio, 95% confidence interval.
*France, Spain and Japan combined.
doi:10.1371/journal.pone.0061044.t002
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P=0.26, respectively; Table 2, Figure 2). BANK1 rs3733197 and
BLK rs13277113 showed no epistasis in the Japanese population
(ORinteraction = 1.15 [0.77–1.72], Pinteraction=0.49). Meta-analysis of
the combined sets (i.e., French, Spanish and Japanese populations)
confirmed the epistatic interaction between BANK1 rs3733197 and
BLK rs13277113 (ORinteraction = 1.17 [1.01–1.36], Pinterac-
tion=0.037), and results were homogeneous among the different
populations (Q-test [2 df] = 0.85, P=0.65, I2 = 0%). Concordant
with results observed in the European Caucasian population, for
the combined set, the association of the G risk allele of BANK1
rs3733197 and RA was restricted to subjects carrying the BLK
rs13277113 GG genotype (ORG|GG(meta) = 1.21 [1.04–1.41],
P=0.015; Table 2, Figure 2).
The MB-MDR test for BANK1 rs3733197 and BLK rs13277113
also provided significant results for the European samples (France
and Spain combined and adjusted on country of origin) leading to
a Wald statistics maximum (Wmax) of 9.44 for the high-risk GG-
GG genotype and a P-value of 0.036 (assessed with 500
permutations) with 95% CI 0.019–0.052. No findings were
significant for the Japanese sample, and the GG-GG genotype
combination was not classified as high risk (Table 3).
We found no significant interaction of BANK1 rs10516487 and
BLK rs13277113, whatever the population investigated (data not
shown).
The systematic review retrieved 2 studies [14,15] (Figure S1). In
combining our results with those of all association studies of the
two BANK1 SNPs and RA in a large trans-ethnic meta-analysis, we
found an association of the functional BANK1 rs3733197
polymorphism and RA, with the G allele conferring increased
risk (OR=1.11, [1.02–1.21], P=0.012) (Figure 3). Similar ORs,
although not significant, were obtained for non-European
Caucasian populations (OR=1.11 [0.86–1.43]; P=0.42), proba-
bly because of smaller sample sizes than for the European
Caucasian populations. The power (at p,0.05) to detect the effect
of the G risk allele of BANK1 rs3733197 in the non-European
populations was only 21.8% as compared with 60% for the
European Caucasian populations. Effects were homogenous
between all samples (Q-test = 5.97, P=0.314; I2 = 16.3% [0%–
78.8%]). Case–case analyses failed to detect any association with
specific autoantibody status (ACPA and RF) (data not shown).
Meta-analysis of the BANK1 rs10516487 variant (R61H), which is
functional [15], remained inconclusive, with an estimated OR of
1.06 ([1.00–1.12], P= 0.055; I2 = 13% [0%–74.6%]) for the
Table 3. Distribution of BLK-rs13277113 and BANK1-rs3733197 multilocus genotypes in cases and control populations from Spain,
France and Japan.
Country BLK rs13277113 BANK1 rs3733197 Cases Controls Beta P-value Risk category
Spain AA AA 3 3 20.21 0.79 0
AG AA 12 13 20.30 0.46 0
GG AA 14 20 20.59 0.09 L
AA AG 13 8 0.28 0.54 0
AG AG 61 51 20.04 0.85 0
GG AG 125 104 20.04 0.81 0
AA GG 8 17 20.99 0.02 L
AG GG 89 68 0.07 0.69 0
GG GG 136 89 0.28 0.07 H
France AA AA 8 6 0.69 0.20 0
AG AA 37 50 0.10 0.64 0
GG AA 43 63 0.02 0.92 0
AA AG 17 35 20.33 0.27 0
AG AG 117 206 20.19 0.12 0
GG AG 204 323 20.07 0.44 0
AA GG 22 30 0.09 0.74 0
AG GG 126 202 20.08 0.49 0
GG GG 232 288 0.25 0.01 H
Japan AA AA 5 4 20.45 0.49 0
AG AA 10 1 1.64 0.12 0
GG AA 0 2 22.29 0.23 0
AA AG 90 29 0.51 0.02 H
AG AG 54 34 20.24 0.30 0
GG AG 20 10 0.02 0.97 0
AA GG 212 106 0.02 0.87 0
AG GG 204 107 20.05 0.74 0
GG GG 39 29 20.41 0.11 0
Number of cases and controls, beta coefficient for logistic regression, corresponding p-value and risk category (‘‘H’’ for high risk, ‘‘L’’ for low risk and ‘‘O’’ for unclassified)
from Model Based Multifactor Dimensionality Reduction analysis for each multilocus genotype.
doi:10.1371/journal.pone.0061044.t003
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association of the G allele and RA risk. The results were similar
when restricting the analysis to European Caucasian populations
or non-European Caucasian populations.
Discussion
This study provides the first evidence of a contribution of the
BANK1 gene to RA susceptibility. It suggests that BANK1 does not
play a role in RA individually but only when interacting with BLK.
In addition, this is the first report providing some evidence of
epistasis between two RA susceptibility genes.
BLK has been convincingly established as an RA susceptibility
gene, but the role of BANK1 was uncertain: results of a previous
meta-analysis were inconclusive and prompted us to investigate
ethnic groups not investigated in the first meta-analysis [13].
Although we failed to detect any significant individual association
for the two BANK1 SNPs we investigated, the large trans-ethnic
meta-analysis provided evidence for an association of BANK1
rs3733197 and RA (OR=1.11, [1.02–1.21], P=0.015) (Figure 3).
The clustering of multiple autoimmune disorders in families and
evidence for autoimmune pleiotropic loci are well known. With
evidence for an association of BANK1 and RA, both BANK1 and
BLK should be considered pleiotropic genes involved in the genetic
background of distinct autoimmune phenotypes including SLE,
SSc, Sjo¨gren’s syndrome and now RA. Interestingly, a genetic
interaction between BANK1 and BLK was recently identified in
SLE [27]. Although the BANK1–BLK epistasis previously described
in SLE involves different variants than those we investigated, our
results strengthen the concept of pleiotropic genes and, even more
importantly, pleiotropic genetic interactions pointing to a B-cell
specific pathway that could be relevant in both SLE and RA
pathogenesis.
BLK encodes a tyrosine kinase involved in the regulation of B-
cell activation, and BANK1 encodes for a B-cell adaptor protein
[7,37]. B lymphocytes play several critical roles in the pathogenesis
of RA. They are the source of RF and ACPA and are involved in
antigen presentation to T cells and cytokine production. The
success of B-cell depletion therapy in RA illustrates the importance
of this specific lymphocyte compartment [38]. Despite lack of
functional or mechanistic data, an important limitation of this
study, our results revealed an epistasis between a functional BLK
variant and a BANK1 non-synonymous variant (A383T) in exon 7,
which encodes the ankyrin repeat-like motif [8,17]. Consequently,
both BANK1 and BLK disease-associated variants could contribute
to sustained B-cell receptor signaling and B-cell hyperactivity.
Further genetic association studies, involving large samples, are
required to replicate our findings and better specify the putative
role of BANK1–BLK epistasis in modulating the autoantibody
Figure 3. Meta-analysis of association of BANK1 alleles and rheumatoid arthritis. Number of cases and controls; frequency of the G allele in
cases and controls; and OR, 95% CI and P-value for the association for each population separately and for European Caucasians and non-European
Caucasians and the combined dataset. All data were obtained from the literature, except for the France and Japan data, for which new genotyping
was performed for this study.
doi:10.1371/journal.pone.0061044.g003
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status of RA, although we did not detect an association related to a
particular ACPA status.
Of interest, Castillejo-Lo´pez et al. recently demonstrated that B-
cell receptor stimulation enhanced BANK1 and BLK binding
[27], so genetics may guide the identification of true functional
biological pathways in complex diseases [39]. Saijo et al. showed
that mice triple deficient in the Src-family protein tyrosine kinases
BLK and LYN but not single-deficient or SYK-deficient mice
showed impaired NF-kappaB induction and B-cell development
[40]. BANK1 contains several predicted motifs for binding the
SH2 and SH3 domains of Src kinases. Therefore, BANK1–BLK
epistasis may have specific functional consequences for B cells,
which might be involved in RA pathogenesis.
In our samples of about 2,000 cases and 2,000 controls, we
found no association of BANK1 or BLK and RA but rather a
significant genetic interaction. Taking into account the growing
evidence that epistasis contributes to risk for complex diseases [41–
43], our findings illustrate that accounting for gene–gene
interactions might be necessary to identify genetic effects that
could otherwise be missed. Indeed, the univariate approach
considering only a single marker at a time, commonly used in
genome-wide association studies, could overlook the complex
interactions that often occur in biological systems [44].
Unexpectedly, the BANK1–BLK epistasis we identified involves
the BLK rs13277113 GG genotype found protective in SLE. Such
an inverse association could be surprising, but there are several
examples of variants having opposite effects in distinct auto-
immune diseases [45]. Another striking feature of the data is the
huge difference in BLK rs13277113 minor allele frequency
between the European samples and the Japanese sample. The G
allele is indeed the major allele in Europe and the minor allele in
Japan. Because of this difference, which could be due to
differential selection between populations of different ancestry,
use of the Japanese population as a replication sample to assess the
BANK1–BLK epistasis detected in the European samples is difficult.
Indeed, in terms of the multilocus genotype distribution in the
Japanese sample (Table 3), the frequency of the GG-GG genotype
combination was similar in cases and controls. However, the OR
for the G allele of BANK1 rs3733197 was increased for the GG
genotype as compared with the AG and AA genotypes of BLK
rs13277113. Consequently, independent replication is mandatory
before definitely establishing the contribution of BANK1–BLK
epistasis to RA susceptibility. Detecting and replicating true
epistasis has been difficult and represents a challenge in
deciphering the genetic architecture of complex diseases [41,46].
In summary, BANK1 contributes to the RA genetic susceptibility
background, but the association may depend on the BLK
rs13277113 genotype, in that our results suggest an epistasis
between BANK1 and BLK. This epistasis could explain the
discrepancies in the various reported association studies and
suggest that BANK1 rs3733197 status should be re-analyzed for
BLK rs13277113 status. Our findings illustrate the concept of
pleiotropic epistatic interaction and suggest that BANK1 and BLK
might play a role in RA pathogenesis.
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